These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8665538)

  • 21. The effect of cisapride and ranitidine as monotherapies and in combination in the treatment of uncomplicated gastric ulceration.
    Stubberöd A; Glise H; Hallerbäck B; Solhaug JH
    Scand J Gastroenterol; 1995 Feb; 30(2):106-10. PubMed ID: 7732330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo.
    Feldman M; Smith HJ
    Gastroenterology; 1987 Jan; 92(1):171-4. PubMed ID: 3781184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ; Schuurkes JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisapride treatment of constipation in Parkinson's disease.
    Jost WH; Schimrigk K
    Mov Disord; 1993 Jul; 8(3):339-43. PubMed ID: 8341299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hypotensive effect of cisapride in rat.
    Onat F; Yeğen B; Berkman K; Oktay S
    Gen Pharmacol; 1994 Oct; 25(6):1253-6. PubMed ID: 7875553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
    Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
    Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe proarrhythmias in cisapride therapy. Simple precautionary measures reduce the risk].
    Darpö B
    Lakartidningen; 1997 Nov; 94(47):4317-20. PubMed ID: 9424525
    [No Abstract]   [Full Text] [Related]  

  • 28. Cisapride-induced long QT interval: what is the role of ranitidine?
    Gunasekaran TS; DuBrow I
    J Pediatr; 1997 Apr; 130(4):679-80. PubMed ID: 9108876
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect and mechanism of the prokinetic action of cisapride on gastrointestinal smooth muscle.
    Chen HT; Goh MH; Pan S
    Gastroenterol Jpn; 1993 Apr; 28(2):218-23. PubMed ID: 8486211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisapride enhances detrusor contractility and improves micturition in a woman with lazy bladder.
    Franceschetti GP; Candura SM; Vicini D; Tonini M
    Scand J Urol Nephrol; 1997 Apr; 31(2):209-10. PubMed ID: 9165590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study.
    Wager E; Tooley PJ; Pearce GL; Wilton LV; Mann RD
    Eur J Clin Pharmacol; 1997; 52(2):87-94. PubMed ID: 9174676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Syncope with long QT interval in a 39 day-old infant treated with cisapride].
    Valdes L; Champel V; Olivier C; Jonville-Bera AP; Autret E
    Arch Pediatr; 1997 Jun; 4(6):535-7. PubMed ID: 9239268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinsonian tremor.
    Braham J
    Neurology; 1993 Feb; 43(2):456-7. PubMed ID: 8437727
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
    Linnik MD; Butler BT; Gaddis RR; Ahmed NK
    J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cisapride on salivary production in normal subjects.
    Patel R; Launspach J; Soffer E
    Dig Dis Sci; 1996 Mar; 41(3):480-4. PubMed ID: 8617119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson's disease.
    Jost WH; Schimrigk K
    Wien Klin Wochenschr; 1994; 106(21):673-6. PubMed ID: 7810153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoprotective activity of cisapride on experimental gastric mucosal lesions induced by ethanol. Role of endogenous prostaglandins.
    Motilva V; López A; Martín MJ; La Casa C; Alarcón de la Lastra C
    Prostaglandins; 1996 Jul; 52(1):63-74. PubMed ID: 8875638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long QT syndrome under cisapride in neonates and infants].
    Lupoglazoff JM; Bedu A; Faure C; Denjoy I; Casasoprana A; Cézard JP; Aujard Y
    Arch Pediatr; 1997 Jun; 4(6):509-14. PubMed ID: 9239264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two dosing regimens of cisapride in the treatment of reflux oesophagitis.
    Schütze K; Bigard MA; Van Waes L; Hinojosa J; Bedogni G; Hentschel E
    Aliment Pharmacol Ther; 1997 Jun; 11(3):497-503. PubMed ID: 9218072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.